Literature DB >> 24443406

Ontario's ColonCancerCheck: results from canada's first province-wide colorectal cancer screening program.

Linda Rabeneck1, Jill M Tinmouth, Lawrence F Paszat, Nancy N Baxter, Loraine D Marrett, Arlinda Ruco, Nancy Lewis, Julia Gao.   

Abstract

BACKGROUND: ColonCancerCheck (CCC), Canada's first province-wide colorectal cancer screening program, was publicly launched in Ontario in April 2008. The objective of this article is to report on key indicators of CCC Program performance since its inception.
METHODS: The CCC Program recommends biennial guaiac-based fecal occult blood test (gFOBT) for persons 50 to 74 years of age at average risk for colorectal cancer and colonoscopy for those at increased risk (having one or more first-degree relatives with a diagnosis of colorectal cancer). Opportunistic screening with colonoscopy is available in Ontario. Five data sources were used to compute indicators of program performance during 2008 to 2011. The indicators computed were FOBT participation, overdue for screening, FOBT positivity, positive predictive value (PPV) of FOBT for colorectal cancer, diagnostic follow-up, and colorectal cancer detection rate.
RESULTS: In 2011, FOBT participation was 29.8% and 46.8% of the target population was overdue for screening. FOBT positivity was higher among men (5.1%) than women (3.5%), and the PPV of FOBT for cancer was 4.3% in 2011. Follow-up colonoscopy within 6 months of a positive FOBT was completed by 74.6% of Program participants in 2011. The cancer detection rates for FOBT and for colonoscopy in those with a family history were 1.3 per 1,000 and 4.0 per 1,000, respectively, in 2011.
CONCLUSION: These results provide an early indication of Program performance and provide findings relevant to other organized colorectal cancer screening programs. IMPACT: The greater cancer detection rate in those at increased risk due to family history who undergo colonoscopy screening suggests that a strategy of risk stratification will enhance the impact of FOBT-based screening programs. ©2014 AACR.

Entities:  

Mesh:

Year:  2014        PMID: 24443406     DOI: 10.1158/1055-9965.EPI-13-0956

Source DB:  PubMed          Journal:  Cancer Epidemiol Biomarkers Prev        ISSN: 1055-9965            Impact factor:   4.254


  19 in total

1.  The impact of stratifying by family history in colorectal cancer screening programs.

Authors:  Simon Lucas Goede; Linda Rabeneck; Iris Lansdorp-Vogelaar; Ann G Zauber; Lawrence F Paszat; Jeffrey S Hoch; Jean H E Yong; Frank van Hees; Jill Tinmouth; Marjolein van Ballegooijen
Journal:  Int J Cancer       Date:  2015-02-20       Impact factor: 7.396

2.  Screening for a new primary cancer in patients with existing metastatic cancer: a retrospective cohort study.

Authors:  Matthew C Cheung; Jill Tinmouth; Peter C Austin; Hadas D Fischer; Kinwah Fung; Simron Singh
Journal:  CMAJ Open       Date:  2018-11-07

3.  Do Primary Care Provider Strategies Improve Patient Participation in Colorectal Cancer Screening?

Authors:  Nancy N Baxter; Rinku Sutradhar; Qing Li; Corinne Daly; Gladys N Honein-AbouHaidar; Devon P Richardson; Lisa Del Giudice; Jill Tinmouth; Lawrence Paszat; Linda Rabeneck
Journal:  Am J Gastroenterol       Date:  2017-02-28       Impact factor: 10.864

4.  The compliance rate for the second diagnostic evaluation after a positive fecal occult blood test: A systematic review and meta-analysis.

Authors:  Rachel Gingold-Belfer; Haim Leibovitzh; Doron Boltin; Nidal Issa; Tsachi Tsadok Perets; Ram Dickman; Yaron Niv
Journal:  United European Gastroenterol J       Date:  2019-02-06       Impact factor: 4.623

Review 5.  Recommendations on Fecal Immunochemical Testing to Screen for Colorectal Neoplasia: A Consensus Statement by the US Multi-Society Task Force on Colorectal Cancer.

Authors:  Douglas J Robertson; Jeffrey K Lee; C Richard Boland; Jason A Dominitz; Francis M Giardiello; David A Johnson; Tonya Kaltenbach; David Lieberman; Theodore R Levin; Douglas K Rex
Journal:  Am J Gastroenterol       Date:  2016-10-18       Impact factor: 10.864

6.  Association Between Time to Colonoscopy After a Positive Fecal Test Result and Risk of Colorectal Cancer and Cancer Stage at Diagnosis.

Authors:  Douglas A Corley; Christopher D Jensen; Virginia P Quinn; Chyke A Doubeni; Ann G Zauber; Jeffrey K Lee; Joanne E Schottinger; Amy R Marks; Wei K Zhao; Nirupa R Ghai; Alexander T Lee; Richard Contreras; Charles P Quesenberry; Bruce H Fireman; Theodore R Levin
Journal:  JAMA       Date:  2017-04-25       Impact factor: 56.272

7.  Mailed participant reminders are associated with improved colonoscopy uptake after a positive FOBT result in Ontario's ColonCancerCheck program.

Authors:  David Stock; Linda Rabeneck; Nancy N Baxter; Lawrence F Paszat; Rinku Sutradhar; Lingsong Yun; Jill Tinmouth
Journal:  Implement Sci       Date:  2015-03-13       Impact factor: 7.327

8.  Disease Monitoring and Health Campaign Evaluation Using Google Search Activities for HIV and AIDS, Stroke, Colorectal Cancer, and Marijuana Use in Canada: A Retrospective Observational Study.

Authors:  Rebecca Ling; Joon Lee
Journal:  JMIR Public Health Surveill       Date:  2016-10-12

9.  Decreased Colorectal Cancer Incidence and Incidence-Based Mortality in the Screening-Age Population of Ontario.

Authors:  Lawrence F Paszat; Rinku Sutradhar; Elyse Corn; Jill Tinmouth; Nancy N Baxter; Linda Rabeneck
Journal:  J Can Assoc Gastroenterol       Date:  2020-10-15

10.  Interval Colorectal Cancers following Guaiac Fecal Occult Blood Testing in the Ontario ColonCancerCheck Program.

Authors:  Lawrence Paszat; Rinku Sutradhar; Jill Tinmouth; Nancy Baxter; Linda Rabeneck
Journal:  Can J Gastroenterol Hepatol       Date:  2016-05-08
View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.